HOLLY AZIMI: Open Payments
NPI 1487022273 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 69 payments from 14 companies in 2025. Trend: 2023 $1,347 · 2024 $1,243 · 2025 $1,418
Food & beverage: $1,360Education: $57
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $292 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $176 |
| United Therapeutics Corporation | 5 | $141 |
| Insmed, Inc. | 7 | $137 |
| Grifols USA, LLC | 4 | $113 |
| Verona Pharma, Inc. | 4 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
Products named: TRELEGY ELLIPTA, DUPIXENT, Arikayce, Prolastin-C Liquid, Ohtuvayre, AIRSUPRA, OFEV, Tyvaso.
Industry payments across GA — which companies pay providers there.
